학술논문

GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma
Document Type
Article
Source
In: Journal of Neuro-Oncology. (Journal of Neuro-Oncology, 1 May 2020, 147(3):577-585)
Subject
Language
English
ISSN
15737373
0167594X